NCT00632554已完成4 期
Phase 4, Randomized Study of Three Months-prednisolone Therapy in the Treatment of Chronic Eosinophilic Pneumonia
Hamamatsu University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2008年6月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- Efficacy of 3 versus 6 months-prednisolone therapy for chronic eosinophilic pneumonia
研究概览
简要总结
A comparison of 3 months-prednisolone administration with 6 months-prednisolone therapy in the treatment of chronic eosinophilic pneumonia. Three months-prednisolone administration may be as effective as 6 months-therapy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 16 Years 至 80 Years(Child, Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Biopsy-proven chronic eosinophilic pneumonia
排除标准
- •Patients who received oral glucocorticosteroid (more than 10 mg)
- •Immunosuppressive drug
研究组 & 干预措施
1
Experimental
prednisolone therapy for three months
干预措施: prednisolone 0.5 mg/kg/day for three months (Drug)
2
Active Comparator
prednisolone therapy for six months
干预措施: prednisolone 0.5 mg/kg/day for six months (Drug)
结局指标
主要结局
Efficacy of 3 versus 6 months-prednisolone therapy for chronic eosinophilic pneumonia
时间窗: Three years
次要结局
- Safety of 3 versus 6 months-prednisolone therapy for chronic eosinophilic pneumonia(Three years)
研究者
Naoki Inui
Department of Respiratory Medicine
Hamamatsu University
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Prednisolone in Early Diffuse Systemic SclerosisSystemic SclerosisNCT03708718Prof. Ariane herrick35
招募中
3 期
Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric PopulationCataracts InfantileNCT05724446Salvat60
尚未招募
3 期
Short-Term Versus 6-Week Prednisone in The Treatment of Subacute ThyroiditisSubacute ThyroiditisNCT06285617Xinqiao Hospital of Chongqing600
招募中
2 期
Effect of Prednisolone on treatment of COVID-19COVID-19 disease.COVID-19U07.2, U07IRCT20081027001411N3Tehran University of Medical Sciences60
已完成
3 期
Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host DiseaseGraft Versus Host DiseaseRecurrent Adult Acute Lymphoblastic LeukemiaNCT00929695Fred Hutchinson Cancer Center164
